Fresenius eyes Sorin's renal care business - paper

FRANKFURT, April 10 (Reuters) - Fresenius (FREG.DE: Quote, Profile, Research) is in talks to buy Italian group Sorin's (SORN.MI: Quote, Profile, Research) renal care business which had sales of 100 million euros ($159 million) last year, the Financial Times Deutschland newspaper reported.

The paper quoted industry sources as saying that Fresenius was being advised by Societe Generale while Morgan Stanley was working for Sorin, whose renal care unit makes dialysis machines.

Fresenius Medical Care (FMEG.DE: Quote, Profile, Research) (FMC), 36 percent owned by Fresenius, is the world's biggest dialysis company.

A spokesman at Fresenius declined to comment on what he called market speculation.

Fresenius shares were up 2 percent at 54.95 euros, while FMC was flat. In Italy, Sorin shares were down 1.8 percent. (Reporting by Mantik Kusjanto; editing by Rory Channing)